Ibverine C Tablet is a combination medication containing Mebeverine 135 mg and Chlordiazepoxide 5 mg, formulated for the management of irritable bowel syndrome (IBS) and related gastrointestinal disorders characterized by abdominal pain, cramps, and altered bowel habits. Mebeverine is an antispasmodic agent that acts directly on the smooth muscle of the gastrointestinal tract, relieving muscle spasms without affecting normal gut motility. This action helps alleviate abdominal discomfort and cramping associated with IBS. Chlordiazepoxide, a benzodiazepine derivative, possesses anxiolytic and muscle-relaxant properties, which contribute to the reduction of anxiety and stress that often exacerbate gastrointestinal symptoms. The combination of these two agents provides a dual mechanism of action, addressing both the physical and psychological components of functional bowel disorders. Ibverine C is typically administered orally, with dosage and duration determined by the prescribing physician based on individual patient needs and response. It is contraindicated in patients with hypersensitivity to either component, severe hepatic or renal impairment, and should be used cautiously in individuals with a history of substance abuse or dependence. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Patients are advised to avoid alcohol and operate machinery with caution while on this medication.